CAZZANIGA, GIOVANNI
CAZZANIGA, GIOVANNI
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
A novel RTEL1 nonsense variant in a case of familial pulmonary fibrosis: clinical description and genetic implications
2025 Franco, G; Bertola, F; Aloisi, F; Promi, S; Zanini, U; Faverio, P; Bentivegna, A; Borie, R; Crestani, B; Cazzaniga, G; Luppi, F
Biallelic PI4KA Mutations Disrupt B-Cell Metabolism and Cause B-Cell Lymphopenia and Hypogammaglobulinemia
2025 Saettini, F; Guerra, F; Mauri, M; Salter, C; Adam, M; Adams, D; Baple, E; Barredo, E; Bhatia, S; Borkhardt, A; Brusco, A; Bugarin, C; Chinello, C; Crosby, A; D'Souza, P; Denti, V; Fazio, G; Giuliani, S; Kuehn, H; Amel, H; Elmi, A; Lo, B; Malighetti, F; Mandrile, G; Martín-Nalda, A; Mefford, H; Moratto, D; Emam Mousavi, F; Nelson, Z; Gutiérrez-Solana, L; Macnamara, E; Michaud, V; O'Leary, M; Pagani, L; Pavinato, L; Santamaria, P; Planas-Serra, L; Quadri, M; Raspall-Chaure, M; Rebellato, S; Rosenzweig, S; Roubertie, A; Holzinger, D; Deal, C; Vockley, C; Savino, A; L. Stoddard, J; Uhlig, H; Pujol, A; Magni, F; Paglia, G; Cazzaniga, G; Piazza, R; Barberis, M; Biondi, A
Cohesins: Crossroad Between Cornelia de Lange Spectrum and Cancer Predisposition
2025 Rigotti, L; Rebellato, S; Lettieri, A; Castiglioni, S; Mariani, M; Totaro, S; Saitta, C; Gervasini, C; Fazio, G; Massa, V; Cazzaniga, G; Selicorni, A
Donor-derived CARCIK-CD19 cells engineered with Sleeping Beauty transposon in acute lymphoblastic leukemia relapsed after allogeneic transplantation
2025 Lussana, F; Magnani, C; Galimberti, S; Gritti, G; Gaipa, G; Belotti, D; Cabiati, B; Napolitano, S; Ferrari, S; Moretti, A; Buracchi, C; Borleri, G; Rambaldi, B; Rizzuto, G; Grassi, A; Paganessi, M; Meli, C; Tettamanti, S; Risca, G; Pais, G; Spinozzi, G; Benedicenti, F; Cazzaniga, G; Capelli, C; Gotti, E; Introna, M; Golay, J; Montini, E; Balduzzi, A; Valsecchi, M; Dastoli, G; Rambaldi, A; Biondi, A
Exploring glioblastoma heterogeneity: the impact of ecDNA on tumor evolution and progression
2025 Ghizzi, M; Sirtori, A; Ripamonti, G; Sala, C; Gautiero, E; Sala, E; Redaelli, S; Cazzaniga, G; Bentivegna, A
HDAC7 induction combined with standard-of-care chemotherapy provides a therapeutic advantage in t(4;11) infant B-cell acute lymphoblastic leukemia
2025 De Barrios, O; Ocón-Gabarró, I; Gusi-Vives, M; Collazo, O; Meler, A; Romecín, P; Martínez-Moreno, A; Tejedor, J; Fraga, M; Schneider, P; Bardini, M; Cazzaniga, G; Marschalek, R; Stam, R; Bueno, C; Menéndez, P; Parra, M
Overt and covert genetic causes of pediatric acute lymphoblastic leukemia: ACUTE LYMPHOBLASTIC LEUKEMIA
2025 Stoltze, U; Junk, S; Byrjalsen, A; Cave, H; Cazzaniga, G; Elitzur, S; Fronkova, E; Hjalgrim, L; Kuiper, R; Lundgren, L; Mescher, M; Mikkelsen, T; Pastorczak, A; Strullu, M; Trka, J; Wadt, K; Izraeli, S; Borkhardt, A; Schmiegelow, K
PAX5::AUTS2 childhood B-ALL: a relapse-prone genetic subtype with frequent central nervous system involvement and a poor outcome: ACUTE LYMPHOBLASTIC LEUKEMIA
2025 Caye-Eude, A; Fazio, G; Pastorczak, A; Boer, J; Steinemann, D; Ganguli, D; Sonneveld, E; Haslinger, S; D'Andrea, L; Bradtke, J; Lopes, B; Zaliova, M; Escherich, G; König, M; Fortschegger, K; Inthal, A; Stasevich, I; Emerenciano, M; Trka, J; Castillo, L; Parihar, M; Moorman, A; Bergmann, A; den Boer, M; Młynarski, W; Cazzaniga, G; Cavé, H; Nebral, K; Schinnerl, D; Strehl, S
Analysis of measurable residual disease by IG/TR gene rearrangements: quality assurance and updated EuroMRD guidelines
2024 van der Velden, V; Dombrink, I; Alten, J; Cazzaniga, G; Clappier, E; Drandi, D; Eckert, C; Fronkova, E; Hancock, J; Kotrova, M; Kraemer, R; Montonen, M; Pfeifer, H; Pott, C; Raff, T; Trautmann, H; Cave, H; Schafer, B; van Dongen, J; Trka, J; Bruggemann, M; van der Velden, V; Raff, T; van Dongen, J
Clinical pilot study on microfluidic automation of IGH-VJ library preparation for next generation sequencing
2024 Hess, J; Kotrova, M; Fricke, B; Songia, S; Rigamonti, S; Cavagna, R; Tosi, M; Paust, N; Langerak, A; Spinelli, O; Cazzaniga, G; Bruggemann, M; Hutzenlaub, T
Cytogenetically Balanced Reciprocal Translocation Could Hide Molecular Genomic Unbalances: Implications for Foetal Phenotype Correlation
2024 Villa, N; Redaelli, S; Farina, S; Sala, E; Crosti, F; Cozzolino, S; Verderio, M; Dalpra, L; Roversi, G; Bentivegna, A; Cazzaniga, G; Lavitrano, M; Conconi, D
Distinct pattern of genomic breakpoints in CML and BCR::ABL1-positive ALL: analysis of 971 patients
2024 Hovorkova, L; Winkowska, L; Skorepova, J; Krumbholz, M; Benesova, A; Polivkova, V; Alten, J; Bardini, M; Meyer, C; Kim, R; Trahair, T; Clappier, E; Chiaretti, S; Henderson, M; Sutton, R; Sramkova, L; Stary, J; Polakova, K; Marschalek, R; Metzler, M; Cazzaniga, G; Cario, G; Trka, J; Zaliova, M; Zuna, J
Diverse mechanisms of leukemogenesis associated with PAX5 germline mutation
2024 Bettini, L; Fazio, G; Saitta, C; Piazza, R; Palamini, S; Buracchi, C; Rebellato, S; Santoro, N; Simone, C; Biondi, A; Cazzaniga, G
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis
2024 Crespiatico, I; Zaghi, M; Mastini, C; D'Aliberti, D; Mauri, M; Mercado, C; Fontana, D; Spinelli, S; Crippa, V; Inzoli, E; Manghisi, B; Civettini, I; Ramazzotti, D; Sangiorgio, V; Gengotti, M; Brambilla, V; Aroldi, A; Banfi, F; Barone, C; Orsenigo, R; Riera, L; Riminucci, M; Corsi, A; Breccia, M; Morotti, A; Cilloni, D; Roccaro, A; Sacco, A; Stagno, F; Serafini, M; Mottadelli, F; Cazzaniga, G; Pagni, F; Chiarle, R; Azzoni, E; Sessa, A; Gambacorti Passerini, C; Elli, E; Mologni, L; Piazza, R
First-Hit SETBP1 Mutations Cause a Myeloproliferative Disorder with Bone Marrow Fibrosis Mimicking Triple Negative Myelofibrosis
2024 Fontana, D; Crespiatico, I; Zaghi, M; Mastini, C; D’Aliberti, D; Mauri, M; Mercado, C; Spinelli, S; Crippa, V; Inzoli, E; Manghisi, B; Civettini, I; Ramazzotti, D; Sangiorgio, V; Gengotti, M; Brambilla, V; Aroldi, A; Banfi, F; Barone, C; Orsenigo, R; Riera, L; Riminucci, M; Corsi, A; Breccia, M; Morotti, A; Cilloni, D; Roccaro, A; Sacco, A; Stagno, F; Serafini, M; Mottadelli, F; Cazzaniga, G; Pagni, F; Chiarle, R; Azzoni, E; Sessa, A; Gambacorti-Passerini, C; Elli, E; Mologni, L; Piazza, R
Four Additional Doses of PEG-L-Asparaginase during the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized Study
2024 Conter, V; Valsecchi, M; Cario, G; Zimmermann, M; Attarbaschi, A; Stary, J; Niggli, F; Dalla Pozza, L; Elitzur, S; Silvestri, D; Locatelli, F; Moricke, A; Engstler, G; Smisek, P; Bodmer, N; Barbaric, D; Izraeli, S; Rizzari, C; Boos, J; Buldini, B; Zucchetti, M; Von Stackelberg, A; Matteo, C; Lehrnbecher, T; Lanvers-Kaminsky, C; Cazzaniga, G; Gruhn, B; Biondi, A; Schrappe, M
Idiopathic erythrocytosis: a germline disease?
2024 Elli, E; Mauri, M; D’Aliberti, D; Crespiatico, I; Fontana, D; Redaelli, S; Pelucchi, S; Spinelli, S; Manghisi, B; Cavalca, F; Aroldi, A; Ripamonti, A; Ferrari, S; Palamini, S; Mottadelli, F; Massimino, L; Ramazzotti, D; Cazzaniga, G; Piperno, A; Gambacorti-Passerini, C; Piazza, R
Minimal Residual Disease in Paediatric ALL: Significance and Methodological Approaches
2024 Trka, J; Reiterova, M; Cazzaniga, G; Fronkova, E
NG2 is a target gene of MLL-AF4 and underlies glucocorticoid resistance in MLL-r B-ALL by regulating NR3C1 expression
2024 Lopez-Millan, B; Rubio-Gayarre, A; Vinyoles, M; Trincado, J; Fraga, M; Fernandez-Fuentes, N; Guerrero-Murillo, M; Martinez, A; Velasco-Hernandez, T; Falgas, A; Panisello, C; Valcarcel, G; Sardina, J; Lopez-Marti, P; Javierre, B; Del Valle-Perez, B; Garcia de Herreros, A; Locatelli, F; Pieters, R; Bardini, M; Cazzaniga, G; Rodriguez-Manzaneque, J; Hanewald, T; Marschalek, R; Milne, T; Stam, R; Tejedor, J; Menendez, P; Bueno, C
Prenatal origin of NUTM1 gene rearrangement in infant B-cell precursor acute lymphoblastic leukaemia
2024 Bardini, M; Fazio, G; Abascal, L; Meyer, C; Maglia, O; Sala, S; Palamini, S; Rebellato, S; Marschalek, R; Rizzari, C; Biondi, A; Cazzaniga, G